
A targeted T-cell oncology therapy has successfully treated a second baby with aggressive leukaemia who has remained in remission after …
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

